U.S. Markets open in 8 hrs 33 mins

Lifshitz & Miller LLP Announces Investigation of Acer Therapeutics Inc., Aclaris Therapeutics, Inc., Ideanomics, Inc., L Brands, Inc., Marriott International, Inc., NRC Group Holdings Corp., Omnicell, Inc., and OncoCyte Corporation

NEW YORK, July 26, 2019 /PRNewswire/ --

Acer Therapeutics Inc. (ACER)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with a CRL for EDSIVO.

If you are an ACER investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Aclaris Therapeutics, Inc. (ACRS)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with FDA claims that advertising of Eskata, "makes false or misleading claims" regarding the product's risk and efficacy.

If you are an ACRS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Ideanomics, Inc. (IDEX)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations that Ideanomics' U.S. infrastructure costs were negatively impacting IDEX's bottom line performance.

If you are an IDEX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

L Brands, Inc. (LB)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with the reduction of its annual ordinary dividend to $1.20 from $2.40 beginning with the quarterly dividend paid in March 2019.

If you are an LB investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Marriott International, Inc. (MAR)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with the UK Information Commissioner's Office intent to issue a fine in the amount of  £99,200,396 in relation to the Starwood guest reservation database incident.

If you are an MAR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

NRC Group Holdings Corp. (NRCG)

Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of NRCG to US Ecology, Inc.

If you are an NRC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Omnicell, Inc. (OMCL)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations of OMCL engaging in improper accounting revenue practices.

If you are an OMCL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

OncoCyte Corporation (OCX)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with the Company requiring additional time to complete its ongoing CLIA Validation study of DetermaVu.

If you are an OCX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING.© 2019 Lifshitz & Miller LLP.  The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone:  516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com

 

Cision

View original content:http://www.prnewswire.com/news-releases/lifshitz--miller-llp-announces-investigation-of-acer-therapeutics-inc-aclaris-therapeutics-inc-ideanomics-inc-l-brands-inc-marriott-international-inc-nrc-group-holdings-corp-omnicell-inc-and-oncocyte-corporatio-300891859.html